|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
STEM CELL GENETICS AND GENOMICS |
a Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Department of Oncology, and
b Stem Cell Program, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA;
c Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Key Words. HES1 • Notch signaling pathway • Hematopoietic stem cells • Hematopoietic progenitor cells • Stem cell self-renewal • Cell cycle • bHLH
Correspondence: Curt I. Civin, M.D., The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Bunting-Blaustein Cancer Research Building, Room 2M44, 1650 Orleans Street, Baltimore, Maryland 21231, USA. Telephone: 410-955-8816; Fax: 410-955-8897; e-mail: civincu{at}jhmi.edu
Received November 29, 2005;
accepted for publication February 24, 2006.
Notch signaling is implicated in stem cell self-renewal, differentiation, and other developmental processes, and the Drosophila hairy and enhancer of split (HES) 1 basic helix-loop-helix protein is a major downstream effector in the Notch pathway. We found that HES1 was expressed at high levels in the hematopoietic stem cell (HSC)enriched CD34+/[CD38/Lin] /low subpopulation but at low levels in more mature progenitor cell populations. When CD34+ cells were cultured for 1 week, the level of HES1 remained high in the CD34+ subset that had remained quiescent during ex vivo culture but was reduced in CD34+ cells that had divided. To investigate the effects of HES1 in human and mouse hematopoietic stemprogenitor cells (HSPCs), we constructed conditional lentiviral vectors (lentivectors) to introduce transgenes encoding either wild-type HES1 or a mutant lacking the DNA-binding domain (
BHES1). We found that lentivector-mediated HES1 expression in CD34+ cells inhibited cell cycling in vitro and cell expansion in vivo, associated with upregulation of the cell cycle inhibitor p21cip1/Waf1 (p21). The HES1 DNAbinding domain was required for these actions. HES1 did not induce programmed cell death or alter differentiation in HSPCs, and while short-term repopulating activity was reduced in HES1-transduced mouse and human cells, long-term reconstituting HSC function was preserved. Our data characterize the complex, cell contextdependent actions of HES1 as a major downstream Notch signaling regulator of HSPC function.
This article has been cited by other articles:
![]() |
C. S. Tremblay, F. F. Huang, O. Habi, C. C. Huard, C. Godin, G. Levesque, and M. Carreau HES1 is a novel interactor of the Fanconi anemia core complex Blood, September 1, 2008; 112(5): 2062 - 2070. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sang, H. A. Coller, and J. M. Roberts Control of the Reversibility of Cellular Quiescence by the Transcriptional Repressor HES1 Science, August 22, 2008; 321(5892): 1095 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Alder, R. W. Georgantas III, R. L. Hildreth, I. M. Kaplan, S. Morisot, X. Yu, M. McDevitt, and C. I. Civin Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo J. Immunol., April 15, 2008; 180(8): 5645 - 5652. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lahmar, C. Catelain, S. Poirault, M. Dorsch, J.-L. Villeval, W. Vainchenker, O. Albagli, and E. Lauret Distinct Effects of the Soluble Versus Membrane-Bound Forms of the Notch Ligand Delta-4 on Human CD34+CD38low Cell Expansion and Differentiation Stem Cells, March 1, 2008; 26(3): 621 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Georgantas III, R. Hildreth, S. Morisot, J. Alder, C.-g. Liu, S. Heimfeld, G. A. Calin, C. M. Croce, and C. I. Civin CD34+ hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control PNAS, February 20, 2007; 104(8): 2750 - 2755. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chadwick, M. C. Nostro, M. Baron, R. Mottram, G. Brady, and A.-M. Buckle Notch Signaling Induces Apoptosis in Primary Human CD34+ Hematopoietic Progenitor Cells Stem Cells, January 1, 2007; 25(1): 203 - 210. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
